Prothena reported 22.11 in PE Price to Earnings for its fiscal quarter ending in March of 2022.


Pe Change Date
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
Agios Pharmaceuticals 2.88 0.36 Jun/2025
ALKERMES 13.78 1.23 Jun/2025
Amgen 12.51 28.7 Jun/2025
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Exelixis 23.06 8.49 Jul/2025
Incyte 14.77 134.3 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 42.61 5.9 Jun/2025
Prothena 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025